Aikido pharma provides business update

New york, april 5, 2021 /prnewswire/ -- aikido pharma inc. (nasdaq: aiki) ("aikido" or the "company") today provided a business update. anthony hayes, ceo of aikido pharma, stated, "aikido's primary focus is the commercialization of improved treatments for multiple types of cancer and viral infections through innovative research and development that leverages the power of artificial intelligence and machine learning.
DOMH Ratings Summary
DOMH Quant Ranking